2m 2m 2m 2m 2m 2m 2m
Elevance Health (ELV)
NYSE
$395.16+$0.34 (+0.09%)
Price as of Jun 23, 2026 2:44 PM EDT- $85.7BMarket Cap
- 8.24%1-Year Change
- Healthcare PlansIndustry
Elevance Health (ELV)
$395.16+$0.34 (+0.09%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 199.1B +12.49% | 177.0B +3.31% | 171.3B +9.42% | 156.6B +12.95% | |
Cost of Revenue | 21.2B +7.23% | 19.8B +14.21% | 17.3B +32.67% | 13.0B +19.64% | |
Gross Profit | 177.9B +13.15% | 157.3B +2.09% | 154.0B +7.30% | 143.6B +12.38% | |
Sales and Marketing Expense | 21.0B +4.79% | 20.0B +3,243.07% | 599.0M -96.61% | 17.7B +11.13% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 1.5B +10.98% | 1.4B +57.40% | 885.0M -47.16% | 1.7B +28.65% | |
Total Operating Expenses | 192.4B +13.78% | 169.1B +12,252.59% | 1.4B -99.08% | 148.8B +13.86% | |
Operating Profit | 6.7B -15.11% | 7.9B -7.00% | 8.5B +9.40% | 7.8B -1.97% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -1.0B +21.03% | -851.0M +6.64% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -1.0B +21.03% | -851.0M +6.64% | |
Total Nonoperating Income and Expense | 12.0M +33.33% | 9.0M -99.13% | 1.0B +21.03% | 851.0M +6.64% | |
Income before Taxes | 6.7B -15.11% | 7.9B +2.45% | 7.7B -0.70% | 7.8B -1.97% | |
Income Taxes | 1.0B -45.73% | 1.9B +12.12% | 1.7B -1.49% | 1.8B -4.37% | |
Extraordinary Items | 108.0M +4.85% | 103.0M -76.91% | 446.0M N/A | N/A N/A | |
Net Income | 5.7B -5.32% | 6.0B -0.12% | 6.0B -0.63% | 6.0B -1.29% | |
Net Income from Continuing Operations Applicable to Common | 6.7B -15.11% | 7.9B +2.45% | 7.7B -0.70% | 7.8B -1.97% | |
Basic EPS and Net Income | 25.28 -2.05% | 25.81 +1.69% | 25.38 +1.12% | 25.10 +0.24% | |
Diluted EPS and Net Income | 25.21 -1.83% | 25.68 +1.82% | 25.22 +1.65% | 24.81 +0.32% | |
Basic Weighted Average Shares | 224.0M -3.32% | 231.7M -1.78% | 235.9M -1.71% | 240.0M -1.56% | |
Diluted Weighted Average Shares | 224.6M -3.56% | 232.9M -1.90% | 237.4M -2.22% | 242.8M -1.62% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 9.5B +14.51% | 8.3B +27.00% | 6.5B -11.66% | 7.4B +51.37% | |
Short-Term Investments | 25.9B +2.71% | 25.2B -14.90% | 29.6B +14.11% | 26.0B -1.20% | |
Cash and Cash Equivalents and Short-Term Investments | 35.4B +5.63% | 33.5B -7.34% | 36.1B +8.40% | 33.3B +7.04% | |
Total Current Assets | 63.0B +6.89% | 58.9B -1.81% | 60.0B +7.93% | 55.6B +8.79% | |
Accumulated Depreciation | 4.1B +10.31% | 3.7B +3.75% | 3.5B +26.44% | 2.8B -35.41% | |
Property and Plant and Equipment and Net | 4.7B +0.58% | 4.7B +6.72% | 4.4B +1.00% | 4.3B +10.13% | |
Total Long-Term Assets | 2.3B +7.94% | 2.1B +8.80% | 2.0B +15.43% | 1.7B -0.87% | |
Total Assets | 121.5B +3.94% | 116.9B +7.31% | 108.9B +5.99% | 102.8B +5.45% | |
Income Taxes Payable | 2.1B -1.77% | 2.1B +9.04% | 2.0B -3.15% | 2.0B -27.49% | |
Total Short-Term Debt | 1.2B -37.98% | 2.0B +7.47% | 1.9B +6.18% | 1.8B -5.82% | |
Total Current Liabilities | 41.0B +1.12% | 40.6B -2.90% | 41.8B +5.28% | 39.7B +13.79% | |
Total Long-Term Debt | 30.8B +5.40% | 29.2B +25.69% | 23.2B +4.01% | 22.3B +5.63% | |
Total Long-Term Liabilities | 3.4B +1.65% | 3.3B +91.37% | 1.7B +11.27% | 1.6B -7.19% | |
Total Liabilities | 77.5B +2.66% | 75.5B +8.54% | 69.5B +4.74% | 66.4B +8.23% | |
Retained Earnings | 35.4B +5.50% | 33.5B +5.67% | 31.7B +6.81% | 29.7B +9.73% | |
Total Stockholders Equity | 43.9B +6.21% | 41.3B +5.11% | 39.3B +8.26% | 36.3B +0.68% | |
Total Shares Outstanding | 220.7M -2.97% | 227.5M -2.40% | 233.1M -2.05% | 238.0M -1.58% | |
Cash Flow | |||||
Cash from Operating Activities | 4.3B -26.14% | 5.8B -27.95% | 8.1B -4.02% | 8.4B +0.42% | |
Capital Expenditures | 1.1B -11.15% | 1.3B -3.09% | 1.3B +12.50% | 1.2B +5.98% | |
Cash from Investing Activities | -1.3B -73.99% | -5.2B -7.27% | -5.6B +22.19% | -4.6B -52.69% | |
Dividends Paid | 1.5B +1.39% | 1.5B +8.10% | 1.4B +13.51% | 1.2B +11.32% | |
Cash from Financing Activities | -1.7B -245.68% | 1.2B +135.62% | -3.3B +154.10% | -1.3B -411.58% | |
Financials Ratio | |||||
Gross Margin | 89.36% +0.59% | 88.84% -1.18% | 89.91% -1.93% | 91.68% -0.51% | |
Operating Margin | 3.37% -24.54% | 4.47% -9.98% | 4.96% -0.02% | 4.96% -13.21% | |
Return on Assets | 4.75% -10.31% | 5.30% -6.36% | 5.66% -6.01% | 6.02% -9.26% | |
Return on Equity | 13.29% -10.40% | 14.83% -6.32% | 15.84% -4.90% | 16.65% -5.53% | |
Revenue Growth | 12.49% +277.45% | 3.31% -64.85% | 9.42% -27.30% | 12.95% -5.89% | |
Current Ratio | 1.54 +5.70% | 1.45 +1.12% | 1.44 +2.52% | 1.40 -4.39% | |
Cash Ratio | 0.23 +13.27% | 0.20 +30.73% | 0.16 -16.07% | 0.19 +33.02% | |
Debt-to-Equity Ratio | 0.73 -3.39% | 0.76 +18.28% | 0.64 -3.78% | 0.66 +3.99% | |
Debt-to-Assets Ratio | 0.26 -1.27% | 0.27 +15.87% | 0.23 -1.71% | 0.23 -0.72% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow